SILAB, a world leader in the engineering of natural active ingredients, is commissioning its new powder production unit on its unique site. The company selected the spray-drying technology to transform its active ingredients into a dry form, marketed without preservatives.
SILAB Softcare research teams have demonstrated the clinical efficacy of fructosans from Ophiopogon japonicus in the reduction of flares of atopic dermatitis in Caucasian patients. This clinical study has just been published in the journal Acta Dermato-Venereologica*, following a peer-review process by experts in the field.
understanding of epigenetics mechanisms underlying transcriptomic modulations
during skin stress has become a major priority for dermo-cosmetics research. In
this context, SILAB aimed to study and correlate modulations in the miRNA profile
(miRNome) with modifications of the mRNA profile (transcriptome) in human
fibroblasts submitted to repetitive doses of solar simulated radiations (SSR)
to induce irradiation-induced stress phenotype. SILAB performed an original
screen of irradiation-regulated miRNAs in human fibroblasts that allowed the
identification of two new miRNA-mRNA interactions mediating irradiation-induced
On the occasion of the 49th annual congress of the ESDR (European Society for Dermatology Research), which takes place on September 18-21 in Bordeaux (France), SILAB Softcare, SILAB’s department fully dedicated to the care of compromised skin, introduces its research works on atopic dermatitis having led to the development of AD-RESYL®.